[EN] PIPERIDINE GPCR AGONISTS<br/>[FR] AGONISTES DES RÉCEPTEURS COUPLÉS AUX PROTÉINES G (GPCR) PIPERIDINES
申请人:PROSIDION LTD
公开号:WO2010004344A1
公开(公告)日:2010-01-14
Compounds of formula (I): or pharmaceutically acceptable salts thereof, are GPCR agonists and are useful as for the treatment of diabetes and obesity.
式(I)化合物或其药用盐是GPCR激动剂,可用于治疗糖尿病和肥胖。
PIPERIDINE GPCR AGONISTS
申请人:Fyfe Matthew Colin Thor
公开号:US20100105732A1
公开(公告)日:2010-04-29
Compounds of formula (I): or pharmaceutically acceptable salts thereof, are GPCR agonists and are useful as for the treatment of obesity and diabetes.
化合物(I)的公式或其药学上可接受的盐是GPCR激动剂,并且可用于治疗肥胖症和糖尿病。
Piperidine GPCR Agonists
申请人:Bertram Lisa Sarah
公开号:US20110230507A1
公开(公告)日:2011-09-22
Compounds of formula (I): or pharmaceutically acceptable salts thereof, are GPCR agonists and are useful as for the treatment of diabetes and obesity.
式(I)的化合物或其药学上可接受的盐,是GPCR激动剂,可用于治疗糖尿病和肥胖症。
Piperidine GPCR agonists
申请人:Prosidion Limited
公开号:EP2377864A1
公开(公告)日:2011-10-19
Compounds of formula (I):
or pharmaceutically acceptable salts thereof, are GPCR agonists and are useful as for the treatment of obesity and diabetes.
式(I)化合物:
或其药学上可接受的盐类是 GPCR 激动剂,可用于治疗肥胖症和糖尿病。
[EN] PIPERIDINE GPCR AGONISTS<br/>[FR] AGONISTES DE GPCR PIPÉRIDINIQUES
申请人:PROSIDION LTD
公开号:WO2008081207A1
公开(公告)日:2008-07-10
[EN] Compounds of formula (I): or pharmaceutically acceptable salts thereof, are GPCR agonists and are useful as for the treatment of obesity and diabetes. [FR] L'invention concerne des composés de formule (I) ou des sels pharmaceutiquement acceptables de ces composés, qui sont des agonistes de GPCR et qui trouvent une utilité dans le traitement de l'obésité et du diabète.